NCT Number: NCT02148575
Integrating Palliative Care Into Self-Management of Breast Cancer
The purpose of this study is to test a psycho-educational intervention, Managing Cancer Care: A Personal Guide (MCC), that is intended to improve patients' knowledge of palliative care and to facilitate its timely integration into self-management of their breast cancer. The MCC will be tested with patients with Stage I-IV breast cancer at baseline, one, and three months following enrollment. The intervention group will receive the MCC, and the attention-control group will receive a symptom management toolkit. Participants' family caregivers will also be enrolled to provide information on patients' self-management. Investigators hypothesize that users of MCC, as compared to attention-control participants, will demonstrate improved knowledge, feelings, and behaviors related to self-management of their cancer care. This innovative research can help to establish palliative care as a mainstay of self-management interventions that target serious illnesses.
Looking for future studies?
Notify MeKey information
Conditions
Age range
21 year and older
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
Primary location
Yale-New Haven Hospital, New Haven, Connecticut, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Over the age of 21
- Stage I-IV breast cancer
- Live in the State of Connecticut
- Speak English
- Receiving any kind of treatment for breast cancer
- Prognosis of at least 6 months
Treatment and study plan
Symptom Management Group
BehavioralPrimary outcomes
-
Knowledge of Care Options Test
Time frame: 1 month
-
Knowledge of Care Options Test
Time frame: 3 months
-
Knowledge of Care Options Test
Time frame: baseline
Secondary outcomes
-
Control Preferences Scale
Time frame: 1 month
-
Medical Communication Competence Scale
Time frame: 1 month
-
Measurement of Transitions Scale
Time frame: 1 month
-
Chronic Disease Self-Efficacy Scale
Time frame: 1 month
-
Hospital Anxiety and Depression Scale
Time frame: 1 month
-
Uncertainty in Illness Scale
Time frame: 1 month
-
Health Care Utilization Form
Time frame: 3 months
-
Goals of Care Conversations Form
Time frame: 1 month
-
Control Preferences Scale
Time frame: 3 months
-
Medical Communication Competence Scale
Time frame: 3 months
-
Measurement of Transitions Scale
Time frame: 3 months
-
Chronic Disease Self-Efficacy Scale
Time frame: 3 months
-
Hospital Anxiety and Depression Scale
Time frame: 3 months
-
Uncertainty in Illness Scale
Time frame: 3 months
-
Goals of Care Conversations Form
Time frame: 3 months
-
Control Preferences Scale
Time frame: baseline
-
Medical Communication Competence Scale
Time frame: baseline
-
Measurement of Transitions Scale
Time frame: baseline
-
Chronic Disease Self-Efficacy Scale
Time frame: baseline
-
Hospital Anxiety and Depression Scale
Time frame: baseline
-
Uncertainty in Illness Scale
Time frame: baseline
-
Goals of Care Conversations Form
Time frame: baseline
Sponsors and collaborators
Lead sponsor
Yale University
Other
Registry information
Important dates
- Study start
- 2014
- Primary completion
- 2016
- Study completion
- 2017
- First posted
- May 28, 2014
- Registry last updated
- Apr 26, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Tumor-Derived FGF19
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsAfrican Cancer Genome: GMD
NCT05754658
Breast Cancer, Breast Diseases
Philadelphia, Pennsylvania, United States
View Trial Details24GUT540 : Meeting of Breast Cancer Patients and Pathologists
NCT07040514
Breast Cancer, Breast Diseases
Lebanon, New Hampshire, United States
View Trial DetailsNeoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer
NCT06604858
Breast Cancer, Breast Diseases
A Coruña, Spain
View Trial Details